Strs Ohio cut its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 25,500 shares of the company’s stock after selling 1,200 shares during the period. Strs Ohio’s holdings in HealthEquity were worth $1,270,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of HQY. Neuburgh Advisers LLC raised its stake in shares of HealthEquity by 0.4% in the first quarter. Neuburgh Advisers LLC now owns 31,968 shares of the company’s stock worth $1,357,000 after buying an additional 112 shares during the period. Glen Harbor Capital Management LLC raised its stake in shares of HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock worth $1,866,000 after buying an additional 154 shares during the period. Elkfork Partners LLC raised its stake in shares of HealthEquity by 0.4% in the first quarter. Elkfork Partners LLC now owns 55,944 shares of the company’s stock worth $2,375,000 after buying an additional 196 shares during the period. State of Alaska Department of Revenue raised its stake in shares of HealthEquity by 4.3% in the first quarter. State of Alaska Department of Revenue now owns 4,850 shares of the company’s stock worth $205,000 after buying an additional 200 shares during the period. Finally, Louisiana State Employees Retirement System raised its stake in shares of HealthEquity by 1.1% in the second quarter. Louisiana State Employees Retirement System now owns 18,100 shares of the company’s stock worth $902,000 after buying an additional 200 shares during the period. Institutional investors and hedge funds own 90.26% of the company’s stock.

HealthEquity, Inc. (NASDAQ:HQY) opened at 44.93 on Friday. HealthEquity, Inc. has a 12 month low of $28.39 and a 12 month high of $54.95. The stock has a 50 day moving average price of $48.74 and a 200 day moving average price of $46.12. The firm has a market cap of $2.69 billion, a price-to-earnings ratio of 84.45 and a beta of 1.73.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.16 by $0.03. The company had revenue of $55.40 million for the quarter, compared to the consensus estimate of $54.77 million. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. The firm’s quarterly revenue was up 25.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.15 EPS. On average, equities analysts expect that HealthEquity, Inc. will post $0.58 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: “Strs Ohio Sells 1,200 Shares of HealthEquity, Inc. (HQY)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.watchlistnews.com/strs-ohio-sells-1200-shares-of-healthequity-inc-hqy/1480411.html.

A number of brokerages have weighed in on HQY. BidaskClub lowered HealthEquity from a “hold” rating to a “sell” rating in a research note on Thursday, August 3rd. Zacks Investment Research lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Friday, August 4th. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Cantor Fitzgerald raised their price objective on HealthEquity from $50.00 to $55.00 and gave the company an “overweight” rating in a research note on Wednesday, June 7th. Finally, Chardan Capital raised their price objective on HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research note on Wednesday, June 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the stock. HealthEquity presently has an average rating of “Buy” and an average target price of $50.22.

In other news, insider Stephen Neeleman sold 8,500 shares of the stock in a transaction on Monday, July 17th. The stock was sold at an average price of $50.83, for a total value of $432,055.00. Following the transaction, the insider now owns 1,000 shares of the company’s stock, valued at approximately $50,830. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Frank Medici sold 537,102 shares of the stock in a transaction on Friday, July 14th. The shares were sold at an average price of $51.24, for a total value of $27,521,106.48. Following the completion of the transaction, the director now directly owns 6,381 shares in the company, valued at approximately $326,962.44. The disclosure for this sale can be found here. In the last three months, insiders sold 2,440,821 shares of company stock worth $125,325,268. 29.00% of the stock is currently owned by company insiders.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.